SHIFT AI Newsroom · GLOBAL
Systematic Review Investigates Malnutrition and Metabolic Failure in High-Potency Incretin Therapy
A recent systematic review and meta-analysis explores the relationship between high-potency incretin therapy and the risk of malnutrition and metabolic failure.
Introduction
A recent systematic review and meta-analysis has been published investigating the relationship between high-potency incretin therapy and the risk of malnutrition and metabolic failure.
Background
Incretin therapy is used to treat conditions such as type 2 diabetes.
Research
The systematic review and meta-analysis aimed to explore the potential risks associated with high-potency incretin therapy.
What this means in the UK
This research is relevant to the UK as it may impact the treatment and management of conditions where incretin therapy is used, such as type 2 diabetes.
Known facts
- A systematic review and meta-analysis has been conducted to investigate the relationship between high-potency incretin therapy and malnutrition and metabolic failure.